09:53 AM EST - Theralase Technologies Inc. : announced today that it is partnering with JSS Medical Research Inc., a Montreal based Contract Research Organization, to consult and provide guidance in the completion of a FDA / Health Canada Phase I/IIa clinical study. The clinical study planned for early 2015 will evaluate the safety and efficacy of Theralase's innovative Photo Dynamic Therapy platform in the destruction of bladder cancer. Theralase Technologies Inc.
shares V.TLT are trading up $0.005 at $0.33.
